EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Regulatory mechanisms of O6-methylguanine methyltransferase expression in glioma cells

Cheng Fang iD, Guangtao Zhang iD, Shilu Ye iD, Shen Tian iD, Huaixu Li iD, Fuxing Zuo iD, Jinghai Wan iD, Hongqing Cai iD

Science Progress · 2025-04 · 108 (2)

DOI: 10.1177/00368504251345014 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Science Progress, online erschienen am 16.06.2025. Verfasst von Cheng Fang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences …. Hauptthemen laut MEDLINE: Glioma, Gene Expression Regulation, Neoplastic, O(6)-Methylguanine-DNA Methyltransferase, DNA Repair Enzymes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the CAMS Innovation Fund for Medical Sciences, Beijing Hope Run Special Fund of Cancer Foundation of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

O6-methylguanine methyltransferase (MGMT), a pivotal DNA repair enzyme, has its dysregulation playing a substantial role in gliomagenesis, the development of therapeutic resistance, and patient prognosis. This narrative review is designed to offer an all-encompassing overview of the intricate regulatory mechanisms that govern MGMT expression in glioma cells. We systematically investigate the diverse levels of regulation that impact MGMT expression in glioma. These include epigenetic regulation, transcriptional control, post-translational modifications, and the influence exerted by the tumor microenvironment. Epigenetically, methylation of CpG islands within the MGMT promoter region represents a critical determinant for gene silencing. Conversely, histone modifications such as H3K4me3 augment MGMT expression. Transcriptionally, a complex network of transcription factors, which encompasses Sp1, p53, and NF-κB, along with signaling pathways like TGF-β, JAK/STAT, and PI3K/AKT, orchestrates MGMT expression in glioma cells. Furthermore, post-translational modifications of MGMT, such as phosphorylation and ubiquitination, are of pivotal importance in modulating its stability and enzymatic activity. The tumor microenvironment, with factors such as oxidative stress, hypoxia, and immune responses, also exerts a significant influence on MGMT expression. This narrative review delves deeper into the relationship between MGMT expression and drug resistance, especially resistance to alkylating chemotherapy agents, and accentuates the significance of evaluating MGMT expression for personalized glioma therapy. By elucidating these regulatory mechanisms, this review endeavors to enhance our understanding of MGMT's role in glioma biology and to provide insights for future therapeutic strategies aimed at surmounting current treatment challenges.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaGene Expression Regulation, NeoplasticO(6)-Methylguanine-DNA MethyltransferaseDNA Repair EnzymesDNA Modification MethylasesTumor Suppressor ProteinsHumansEpigenesis, GeneticTumor MicroenvironmentProtein Processing, Post-TranslationalSignal TransductionDNA MethylationPromoter Regions, Genetic

Stichwörter der Autor:innen

Drug resistanceO6-methylguanine methyltransferasegliomaregulatory mechanisms

Substanzen

O(6)-Methylguanine-DNA MethyltransferaseMGMT protein, humanDNA Repair EnzymesDNA Modification MethylasesTumor Suppressor Proteins

Autor:innen und Institutionen

  • Department of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Neurosurgery, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China.
  • Department of Neurosurgery, The Second People's Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei, Anhui, China.
  • Department of Neurosurgery, Aviation General Hospital, Beijing, China.

ORCID-Profile: Cheng Fang, Guangtao Zhang, Shilu Ye, Shen Tian, Huaixu Li, Fuxing Zuo, Jinghai Wan, Hongqing Cai

Förderung

  • the CAMS Innovation Fund for Medical Sciences
  • Beijing Hope Run Special Fund of Cancer Foundation of China
  • National Natural Science Foundation of China

Zitieren

APA

Fang, C., Zhang, G., Ye, S., Tian, S., Li, H., Zuo, F., Wan, J., & Cai, H. (2025). Regulatory mechanisms of O6-methylguanine methyltransferase expression in glioma cells. Science Progress, 108(2). https://doi.org/10.1177/00368504251345014

Vancouver

Fang C, Zhang G, Ye S, Tian S, Li H, Zuo F, et al. Regulatory mechanisms of O6-methylguanine methyltransferase expression in glioma cells. Science Progress. 2025;108(2). doi:10.1177/00368504251345014

BibTeX
@article{Fang2025,
  author = {Fang, Cheng and Zhang, Guangtao and Ye, Shilu and Tian, Shen and Li, Huaixu and Zuo, Fuxing and Wan, Jinghai and Cai, Hongqing},
  title = {Regulatory mechanisms of O6-methylguanine methyltransferase expression in glioma cells},
  journal = {Science Progress},
  year = {2025},
  volume = {108},
  number = {2},
  doi = {10.1177/00368504251345014}
}
Kostenlos starten →